Tag Archives: ASTRAZENECA VACCINE BOOSTER WORKS AGAINST OMICRON

A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study. Findings from the study, yet to be published in a peer-reviewed medical journal, match those from rivals Pfizer-BioNTech and Moderna which have also found a third dose of their shots works …

Read More »